Mobile Transcranial Magnetic Stimulation

Launched by UNIVERSITY OF REGENSBURG · Nov 12, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called transcranial magnetic stimulation (TMS) for people dealing with depression. TMS is a non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain, which may help improve mood. The trial will involve 5 patients who will receive this treatment in their own homes or nursing homes.

To be eligible for the study, participants should be adults aged 18 to 80 with a diagnosis of depression that's classified as moderate according to a specific rating scale. They must also live in Germany and be able to understand German well enough to follow the study information. However, individuals with certain medical conditions, like serious neurological diseases, or those who have specific implants in their bodies, cannot participate. If eligible, participants can expect to receive TMS in a comfortable setting and contribute to research that could help improve treatment for depression in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • leading diagnosis of a depressive episode according to ICD-10 in the context of a uni- or bipolar disorder
• • moderate depression according to the Hamilton Depression Rating Scale
• • adult persons aged 18-80 of all genders
• • place of residence in Germany and understanding of the German language sufficient to understand the information
• • written declaration of consent
• Exclusion Criteria:
• • Fulfillment of the contraindications for TMS (electrical implants or metallic objects in the body such as pacemakers or insulin pumps, skin diseases on the head)
• • The presence of a serious neurological disease (e.g. cerebrovascular events, neurodegenerative diseases, epilepsy, brain malformation, severe head injuries in the medical history)
• • Participation in another study during the treatment
• • Pregnancy and breastfeeding period